文献速递消化内镜消化道肿瘤与早癌

内镜黏膜下剥离术治疗既往治疗过的浅表非壶腹部十二指肠上皮肿瘤的临床结局

Clinical outcomes of endoscopic submucosal dissection for previously treated superficial non-ampullary duodenal epithelial tumors.
PubMed 文献 · Gastrointest Endosc · 2026-09-30

两组整块切除率(65.5% vs 50.0%)和R0切除率(48.3% vs 37.5%)无显著差异,不良事件相当;既往治疗组单次ESD后残留病变有更高趋势(31.3% vs 6.9%,p=0.079),敏感性分析支持该发现(33.3% vs 6.9%,p=0.041)。所有残留病变经重复内镜切除后均达到完全根除。

要点

  • 既往治疗过的SNADETs行ESD整块和R0切除率与初治组无显著差异
  • 既往治疗组单次ESD后残留病变有更高趋势,敏感性分析差异显著
  • 残留病变可经重复内镜切除达到完全根除,ESD是合理选择

核心结论

  • 既往治疗过的SNADETs行ESD后残留病变率相对较高,但ESD可行且所有患者最终经内镜切除达到临床成功。

主要发现

  • 初治组与既往治疗组整块切除率分别为65.5%与50.0%(p=0.354),R0切除率分别为48.3%与37.5%(p=0.544),不良事件相当。
  • 单次ESD后残留病变在既往治疗组有更高趋势(6.9% vs 31.3%,p=0.079)。
  • 包含全部47例内镜切除的敏感性分析支持该发现(6.9% vs 33.3%,p=0.041)。
  • 主要分析中所有残留病变均接受重复内镜切除,中位随访21个月时所有患者经内镜切除 alone 达到完全肿瘤根除。

临床怎么用

  • 对于既往治疗过的SNADETs,ESD可作为合理的治疗选择,但需注意残留病变风险较高并计划重复内镜切除。

局限性

  • 单中心回顾性研究,样本量较小(37例患者45例ESD),长期结局以单次手术后残留病变评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Endoscopic submucosal dissection (ESD) is increasingly used for superficial non-ampullary duodenal epithelial tumors (SNADETs). However, evidence from the United States (US) is limited. Moreover, the effectiveness and safety of ESD for previously treated SNADETs remain unclear. This study aimed to evaluate the outcomes of ESD for previously treated SNADETs. METHODS: This single-center retrospective cohort study included patients undergoing ESD for SNADETs at a US tertiary center between October 2018 and February 2025. Short-term outcomes (en bloc/R0 resection and adverse events) were compared between treatment-naïve and previously treated groups. Long-term outcomes were assessed by the presence of residual lesions after a single procedure. RESULTS: A total of 45 ESDs in 37 patients were analyzed (29 treatment-naïve and 16 previously treated). En bloc (65.5% vs. 50.0%, p = 0.354) and R0 resection rates (48.3% vs. 37.5%, p = 0.544) did not differ between the groups, with comparable adverse events. Residual lesions after a single ESD tended to be more frequent in the previously treated group (6.9% vs. 31.3%, p = 0.079). Sensitivity analysis including all 47 endoscopic resections (ERs) supported this finding (6.9% vs. 33.3%, p = 0.041). In the primary analysis, all residual lesions were treated with repeat ER, and all patients achieved complete tumor eradication by ER alone (21-month median follow-up). CONCLUSIONS: Despite a relatively high rate of residual lesions following ESD for previously treated SNADETs, ESD was feasible, and all patients ultimately achieved clinical success. ESD for previously treated SNADETs may represent a reasonable treatment option.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Ogata Y, Jiang S, Senda M, et al. Clinical outcomes of endoscopic submucosal dissection for previously treated superficial non-ampullary duodenal epithelial tumors. Gastrointest Endosc. 2026. PMID: 42815696. doi:10.1016/j.gie.2026.09.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。